SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mcbride who wrote (855)1/25/1999 2:05:00 PM
From: LLCF  Read Replies (1) of 998
 
Stock sold off immediately when they even MENTIONED Myotrophin! ha ha ha... CEO refuses to speculate on annual sales number for Provigil, says company will continue trials to expand uses of the drug...(sleep apnia?) quotes nat'l sleep foundation on numbers of people with sleep disorders (60 mill, 11 mill. severe), says drug has big potential beyone Narcolepsy. Says he expects Provigil will make the company profitable in the next couple of years. Closed with "Myotrophin not dead"... at which point the stock sold off.

DAK
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News